186 related articles for article (PubMed ID: 10982197)
1. Is melatonin treatment effective for tardive dyskinesia?
Shamir E; Barak Y; Plopsky I; Zisapel N; Elizur A; Weizman A
J Clin Psychiatry; 2000 Aug; 61(8):556-8. PubMed ID: 10982197
[TBL] [Abstract][Full Text] [Related]
2. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
Shamir E; Barak Y; Shalman I; Laudon M; Zisapel N; Tarrasch R; Elizur A; Weizman R
Arch Gen Psychiatry; 2001 Nov; 58(11):1049-52. PubMed ID: 11695951
[TBL] [Abstract][Full Text] [Related]
3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
Lerner V; Miodownik C; Kaptsan A; Bersudsky Y; Libov I; Sela BA; Witztum E
J Clin Psychiatry; 2007 Nov; 68(11):1648-54. PubMed ID: 18052557
[TBL] [Abstract][Full Text] [Related]
5. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
[TBL] [Abstract][Full Text] [Related]
6. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
[TBL] [Abstract][Full Text] [Related]
8. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
[TBL] [Abstract][Full Text] [Related]
9. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E treatment of tardive dyskinesia.
Adler LA; Peselow E; Rotrosen J; Duncan E; Lee M; Rosenthal M; Angrist B
Am J Psychiatry; 1993 Sep; 150(9):1405-7. PubMed ID: 8102511
[TBL] [Abstract][Full Text] [Related]
11. Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
Lerner V; Miodownik C; Kaptsan A; Cohen H; Matar M; Loewenthal U; Kotler M
Am J Psychiatry; 2001 Sep; 158(9):1511-4. PubMed ID: 11532741
[TBL] [Abstract][Full Text] [Related]
12. Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
Pappa S; Tsouli S; Apostolou G; Mavreas V; Konitsiotis S
Clin Neuropharmacol; 2010; 33(6):271-5. PubMed ID: 21121175
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of melatonin in tardive dyskinesia.
Castro F; Carrizo E; Prieto de Rincón D; Rincón CA; Asián T; Medina-Leendertz S; Bonilla E
Invest Clin; 2011 Sep; 52(3):252-60. PubMed ID: 21950196
[TBL] [Abstract][Full Text] [Related]
14. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
Shriqui CL; Bradwejn J; Annable L; Jones BD
Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
[TBL] [Abstract][Full Text] [Related]
16. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone.
Jeste DV; Okamoto A; Napolitano J; Kane JM; Martinez RA
Am J Psychiatry; 2000 Jul; 157(7):1150-5. PubMed ID: 10873925
[TBL] [Abstract][Full Text] [Related]
18. Oxidative mechanisms and tardive dyskinesia.
Lohr JB; Kuczenski R; Niculescu AB
CNS Drugs; 2003; 17(1):47-62. PubMed ID: 12467492
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
20. [Tardive dyskinesia: pergolid, a possible therapeutic option].
Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
